Why does Pentec Health focus on Albumin levels?
Clinical evidence indicates that patients with sustained Albumin levels below 3.5 g/dL are at greater risk for mortality and morbidity than those with consistently higher levels. At Pentec Health, we believe IDPN and IPN have the potential to stimulate real improvement in patient’s nutritional status for those whose Albumin levels remain below 3.5 g/dL — provided traditional repletion efforts have failed to restore desirable albumin levels.
